Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro

Direct reprogramming of somatic cells into pluripotent cells by retrovirus-mediated expression of OCT4, SOX2, KLF4, and C-MYC is a promising approach to derive disease-specific induced pluripotent stem cells (iPSCs). In this study, we focused on three murine models for metabolic liver disorders: the...

Full description

Saved in:
Bibliographic Details
Main Authors: Reto Eggenschwiler, Komal Loya, Malte Sgodda, Francoise André, Tobias Cantz
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.4061/2011/924782
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561086806622208
author Reto Eggenschwiler
Komal Loya
Malte Sgodda
Francoise André
Tobias Cantz
author_facet Reto Eggenschwiler
Komal Loya
Malte Sgodda
Francoise André
Tobias Cantz
author_sort Reto Eggenschwiler
collection DOAJ
description Direct reprogramming of somatic cells into pluripotent cells by retrovirus-mediated expression of OCT4, SOX2, KLF4, and C-MYC is a promising approach to derive disease-specific induced pluripotent stem cells (iPSCs). In this study, we focused on three murine models for metabolic liver disorders: the copper storage disorder Wilson's disease (toxic-milk mice), tyrosinemia type 1 (fumarylacetoacetate-hydrolase deficiency, FAH−/− mice), and alpha1-antitrypsin deficiency (PiZ mice). Colonies of iPSCs emerged 2-3 weeks after transduction of fibroblasts, prepared from each mouse strain, and were maintained as individual iPSC lines. RT-PCR and immunofluorescence analyses demonstrated the expression of endogenous pluripotency markers. Hepatic precursor cells could be derived from these disease-specific iPSCs applying an in vitro differentiation protocol and could be visualized after transduction of a lentiviral albumin-GFP reporter construct. Functional characterization of these cells allowed the recapitulation of the disease phenotype for further studies of underlying molecular mechanisms of the respective disease.
format Article
id doaj-art-5e95e760fac44d0aa9e4deb597890f05
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-5e95e760fac44d0aa9e4deb597890f052025-02-03T01:26:00ZengWileyStem Cells International1687-966X1687-96782011-01-01201110.4061/2011/924782924782Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In VitroReto Eggenschwiler0Komal Loya1Malte Sgodda2Francoise André3Tobias Cantz4Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, 30625 Hannover, GermanyStem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, 30625 Hannover, GermanyStem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, 30625 Hannover, GermanyStem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, 30625 Hannover, GermanyStem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, 30625 Hannover, GermanyDirect reprogramming of somatic cells into pluripotent cells by retrovirus-mediated expression of OCT4, SOX2, KLF4, and C-MYC is a promising approach to derive disease-specific induced pluripotent stem cells (iPSCs). In this study, we focused on three murine models for metabolic liver disorders: the copper storage disorder Wilson's disease (toxic-milk mice), tyrosinemia type 1 (fumarylacetoacetate-hydrolase deficiency, FAH−/− mice), and alpha1-antitrypsin deficiency (PiZ mice). Colonies of iPSCs emerged 2-3 weeks after transduction of fibroblasts, prepared from each mouse strain, and were maintained as individual iPSC lines. RT-PCR and immunofluorescence analyses demonstrated the expression of endogenous pluripotency markers. Hepatic precursor cells could be derived from these disease-specific iPSCs applying an in vitro differentiation protocol and could be visualized after transduction of a lentiviral albumin-GFP reporter construct. Functional characterization of these cells allowed the recapitulation of the disease phenotype for further studies of underlying molecular mechanisms of the respective disease.http://dx.doi.org/10.4061/2011/924782
spellingShingle Reto Eggenschwiler
Komal Loya
Malte Sgodda
Francoise André
Tobias Cantz
Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
Stem Cells International
title Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
title_full Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
title_fullStr Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
title_full_unstemmed Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
title_short Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
title_sort hepatic differentiation of murine disease specific induced pluripotent stem cells allows disease modelling in vitro
url http://dx.doi.org/10.4061/2011/924782
work_keys_str_mv AT retoeggenschwiler hepaticdifferentiationofmurinediseasespecificinducedpluripotentstemcellsallowsdiseasemodellinginvitro
AT komalloya hepaticdifferentiationofmurinediseasespecificinducedpluripotentstemcellsallowsdiseasemodellinginvitro
AT maltesgodda hepaticdifferentiationofmurinediseasespecificinducedpluripotentstemcellsallowsdiseasemodellinginvitro
AT francoiseandre hepaticdifferentiationofmurinediseasespecificinducedpluripotentstemcellsallowsdiseasemodellinginvitro
AT tobiascantz hepaticdifferentiationofmurinediseasespecificinducedpluripotentstemcellsallowsdiseasemodellinginvitro